{"alopecia": 2.31, "alpha 1 foetoprotein increased": 120.07, "anaemia": 2.17, "ascites": 6.37, "blister": 5.22, "diarrhoea": 3.18, "disease progression": 3.69, "drug ineffective for unapproved indication": 10.39, "drug intolerance": 2.43, "drug-induced liver injury": 4.01, "erythema multiforme": 9.65, "haematotoxicity": 12.91, "hepatic encephalopathy": 14.89, "hepatic failure": 9.18, "hepatic function abnormal": 2.2, "hepatocellular carcinoma": 52.16, "hepatotoxicity": 6.28, "hyperkeratosis": 23.81, "hypertension": 3.52, "hypocalcaemia": 15.93, "leukopenia": 2.03, "metastases to bone": 6.02, "metastases to lung": 25.76, "metastatic renal cell carcinoma": 20.05, "mucosal inflammation": 10.2, "off label use": 6.07, "osteonecrosis of jaw": 11.43, "palmar-plantar erythrodysaesthesia syndrome": 76.71, "product use in unapproved indication": 13.07, "product use issue": 2.98, "rash maculo-papular": 4.91, "renal cell carcinoma": 10.09, "skin exfoliation": 4.11, "skin reaction": 4.72, "skin toxicity": 43.82, "skin ulcer": 6.21, "squamous cell carcinoma of skin": 26.41, "stevens-johnson syndrome": 7.08, "stomatitis": 2.01, "thrombocytopenia": 4.19, "toxicity to various agents": 3.62, "tumour lysis syndrome": 13.16, "weight decreased": 2.48}